Study source | US Microsa | US-SNPsb | Canada Affymetrix | Canada Illuminac | France | UK Cohort 1d | UK Cohort 2e |
---|---|---|---|---|---|---|---|
Ascertainment criteria | 2 ACR+ sibs, 1 with erosions | 2 ACR+ sibs, 1 with erosions | 2 ACR+ sibs | Â | 2 ACR+ sibs | 2 ACR+ sibs | 2 ACR+ sibs |
Number of families | 511 | 757 | 79 | 60 | 88 | 174 | 195 |
Affected sibs/family | 2.13 | 2.15 | 2 | 2 | 2.18 | 2.13 | 2.09 |
% SE+ | 71% | 79% | N/A | N/A | N/A | 90% | 82% |
% Erosion | 95% | 97% | 39% | N/A | N/A | 76% | 71% |
Median age onset | 39.1 | 38.9 | 43.8 | N/A | N/A | 39.3 | 44.0 |
% RF+ | 81.1% | 74.3% | 71.1% | N/A | N/A | 62.5% | 56.7% |